AMPA receptor potentiators as novel antidepressants

A Alt, JM Witkin, D Bleakman - Current pharmaceutical design, 2005 - ingentaconnect.com
Depression affects a large percentage of the general population and can produce
devastating consequences to affected individuals, families and society. Although the …

[引用][C] AMPA receptor potentiators as novel antidepressants: Novel antidepressants/anxiolytics

A ALT, JM WITKIN… - Current pharmaceutical …, 2005 - pascal-francis.inist.fr
AMPA receptor potentiators as novel antidepressants : Novel antidepressants/anxiolytics
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

AMPA receptor potentiators as novel antidepressants

A Alt, JM Witkin, D Bleakman - Current pharmaceutical …, 2005 - pubmed.ncbi.nlm.nih.gov
Depression affects a large percentage of the general population and can produce
devastating consequences to affected individuals, families and society. Although the …

AMPA receptor potentiators as novel antidepressants.

A Alt, JM Witkin, D Bleakman - Current Pharmaceutical Design, 2005 - europepmc.org
Depression affects a large percentage of the general population and can produce
devastating consequences to affected individuals, families and society. Although the …

AMPA Receptor Potentiators as Novel Antidepressants

A Alt, JM Witkin, D Bleakman - Current Pharmaceutical Design, 2005 - search.proquest.com
Depression affects a large percentage of the general population and can produce
devastating consequences to affected individuals, families and society. Although the …

[引用][C] AMPA Receptor Potentiators as Novel Antidepressants

A Alt, J Witkin, D Bleakman - Current Pharmaceutical Design, 2005 - cir.nii.ac.jp
AMPA Receptor Potentiators as Novel Antidepressants | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

[引用][C] AMPA receptor potentiators as novel antidepressants: Novel antidepressants/anxiolytics

A ALT, JM WITKIN, D BLEAKMAN - Current pharmaceutical design, 2005 - Bentham